ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
January 2026
Nuclear Technology
December 2025
Fusion Science and Technology
November 2025
Latest News
The Meta-Vistra deal: A closer look
With last Friday's announcement regarding its vision for nuclear energy, Meta has entered into 20-year power purchase agreements (PPAs) for more than 2,600 MW of electricity from a combination of three Vistra-owned nuclear plants to support the tech behemoth's planned operations in the PJM region.
Yasunori Nakai, Kazuyuki Noborio, Yuto Takeuchi, Ryuta Kasada, Yasushi Yamamoto, Satoshi Konishi
Fusion Science and Technology | Volume 64 | Number 2 | August 2013 | Pages 379-383
Alternate Concepts/Applications | Proceedings of the Twentieth Topical Meeting on the Technology of Fusion Energy (TOFE-2012) (Part 1), Nashville, Tennessee, August 27-31, 2012 | doi.org/10.13182/FST13-A18106
Articles are hosted by Taylor and Francis Online.
An application of a cylindrical discharge tube type fusion neutron beam source for medical purpose was investigated. Practicality and possibility of the medical irradiation plan were evaluated from the standpoint of engineering and medicine.Cancer treatment by BNCT (Boron Neutron Capture Therapy) was selected as an effective application to take advantage of this neutron source. Neutron transport in a phantom was calculated with the MCNP5 (Monte Carlo Neutron Particle calculation code version5), and the distribution of dose on the affected part medicated with a boron agent suggested satisfactory focusing.Since this neutron source is small size, it is designed to irradiate the affected part from many directions by crossfire irradiation. Flexibility of attitude and operation modes permits irradiation in a supine position from arbitrary directions. Because of low neutron flux, irradiation therapy is planned for multi-fractionation in a manner similar to CHART (Continuous Hyperfractionated Accelerated Radio Therapy). Crossfire irradiation and CHART will allow us to achieve new cancer therapy with a relatively lower dose rate than conventional BNCT. It causes apoptosis selectively to a cancer cell, reducing side effects and a patient's recuperation burden. This result suggests the possibility of advanced cancer treatment which improves QOL (Quality of Life) of the patients.